Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ebtesam I Ahmad"'
Publikováno v:
Afro-Egyptian Journal of Infectious and Endemic Diseases.
Background and study aim: MicroRNAs were evaluated as biomarkers for liver injury in various liver diseases. This study aimed to evaluate the serum miRNA-122 as a potential biomarker for diagnosis and monitoring different stages of disease in chronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebbd1a3878aceac5f6cd45298f3c0f90
https://doi.org/10.21608/aeji.2020.30137.1082
https://doi.org/10.21608/aeji.2020.30137.1082
Publikováno v:
Journal of Clinical & Cellular Immunology.
Altered frequency and distribution of natural killer cell subsets have been reported in hepatitis C virus (HCV) infection.We investigated the frequency of NK cells and inhibitory receptor CD158 in a sample of Egyptian patients with spontaneously reso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4cd343109ed577ec38e22ae89ef2810d
https://doi.org/10.4172/2155-9899.1000504
https://doi.org/10.4172/2155-9899.1000504
Publikováno v:
The Egyptian Journal of Haematology. 44:195
Background The Wilms’ tumor 1 (WT1) gene is overexpressed in patients with acute leukemias. Many studies have reported the importance of quantitative assessment of WT1 expression as a molecular marker of minimal residual disease monitoring. However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::290616bc9cabc58636caad9a43b227f4
https://doi.org/10.4103/ejh.ejh_26_19
https://doi.org/10.4103/ejh.ejh_26_19
Publikováno v:
Medical Oncology. 29:1119-1126
We aimed to explore the expression of CD34 and its impact on the disease outcome in patients with APL. The study comprised 40 de novo APL patients. Diagnostic tools included peripheral blood and bone marrow morphology and cytochemistry, immunophenoty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ce58e2c37fc15d2dec6ff02ce846297
https://doi.org/10.1007/s12032-011-9895-y
https://doi.org/10.1007/s12032-011-9895-y
Publikováno v:
OncoTargets and therapy
Ebtesam I Ahmad, Heba H Gawish, Nashwa MA Al Azizi, Ashraf M ElhefniClinical Pathology Department, Hematology and Oncology Unit of Internal Medicine Department, Faculty of Medicine, Zagazig University, Sharkia, EgyptBackground: Activating point mutat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42bc29ff2467d2bc64bb4276b0b59db5
https://www.dovepress.com/the-prognostic-impact-of-k-ras-mutations-in-adult-acute-myeloid-leukem-peer-reviewed-article-OTT
https://www.dovepress.com/the-prognostic-impact-of-k-ras-mutations-in-adult-acute-myeloid-leukem-peer-reviewed-article-OTT
Publikováno v:
Journal of the Egyptian National Cancer Institute. 21(4)
Activating point mutation of the RAS gene has been generally accepted as an oncogenic event in a variety of malignancies. It represents one of the most common genetic alterations in acute myeloid leukemia (AML). However there is still controversy abo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::706cb003c924d66a7abd1e1d05e7116f
https://pubmed.ncbi.nlm.nih.gov/21415871
https://pubmed.ncbi.nlm.nih.gov/21415871